Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 20, 2022
Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario.
read more
Tuesday, September 03, 2019
Bora has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.
read more
Bormioli Pharma, a manufacturer of pharmaceutical packaging and medical devices, announced a significant increase of 47% in its North American sales for 2023. This notable growth is a direct result of the company's rapidly evolving infrastructure and...
read more
Friday, November 08, 2019
Bosch Packaging Technology and Parsolex have entered into a close cooperation on solid dosage manufacturing.
read more
Saturday, September 25, 2021
Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT...
read more
Friday, December 20, 2019
Boston Pharmaceuticals announced the appointment of Joanne Beck, Ph.D., as Chief Operating Officer.
read more
BostonGene, a provider of AI-based molecular and immune profiling solutions, NEC Corporation, a provider of IT, network and AI technologies, and Japan Industrial Partners, a Tokyo-based private equity firm, announced the formation of BostonGene Japan...
read more
Thursday, November 17, 2016
Bracket, a clinical trial technology and specialty services provider, has announced the strategic acquisition of CLINapps Inc., an international software development and consulting firm that offers a comprehensive supply chain management product ...
read more
Tuesday, October 24, 2017
Bracket announced the acquisition of mProve Health, a provider of mobile technologies for life science companies.
read more
Wednesday, November 08, 2017
Bracket announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team.
read more
Bracket has announced that James Jay has joined the Company as Senior Vice President, Endpoint Solutions, reporting to Bracket’s Chief Executive Officer, Mike Nolte. In this role, James will lead the Bracket business focused on eCOA, Rater Training, ...
read more
Friday, February 12, 2021
BrainStorm recently concluded a Type C meeting with the FDA to review aspects of the company's planned manufacturing modifications to support the development of a semi-automated commercial manufacturing process for NurOwn.
read more
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
Tuesday, December 07, 2021
BrainStorm Cell Therapeutics Inc., a developer of cellular therapies for neurodegenerative diseases, and Catalent, a provider of services enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of ...
read more
Tuesday, November 12, 2024
BrainStorm Cell Therapeutics Inc. has entered into a Memorandum of Understanding (MOU) with Pluri Inc. to manufacture NurOwn® for use in BrainStorm's planned Phase 3b trial in amyotrophic lateral sclerosis (ALS).
read more